Literature DB >> 11723030

Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization.

S Yusuf1, S Reddy, S Ounpuu, S Anand.   

Abstract

This two-part article provides an overview of the global burden of atherothrombotic cardiovascular disease. Part I initially discusses the epidemiologic transition which has resulted in a decrease in deaths in childhood due to infections, with a concomitant increase in cardiovascular and other chronic diseases; and then provides estimates of the burden of cardiovascular (CV) diseases with specific focus on the developing countries. Next, we summarize key information on risk factors for cardiovascular disease (CVD) and indicate that their importance may have been underestimated. Then, we describe overarching factors influencing variations in CVD by ethnicity and region and the influence of urbanization. Part II of this article describes the burden of CV disease by specific region or ethnic group, the risk factors of importance, and possible strategies for prevention.

Entities:  

Mesh:

Year:  2001        PMID: 11723030     DOI: 10.1161/hc4601.099487

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  759 in total

1.  Heart failure: a global disease requiring a global response.

Authors:  J E Sanderson; T-f Tse
Journal:  Heart       Date:  2003-06       Impact factor: 5.994

2.  ACE inhibition in stable coronary artery disease.

Authors:  Daniel G Hackam
Journal:  CMAJ       Date:  2003-10-28       Impact factor: 8.262

Review 3.  Is income inequality a determinant of population health? Part 2. U.S. National and regional trends in income inequality and age- and cause-specific mortality.

Authors:  John Lynch; George Davey Smith; Sam Harper; Marianne Hillemeier
Journal:  Milbank Q       Date:  2004       Impact factor: 4.911

Review 4.  Effect of supplemental vitamin E for the prevention and treatment of cardiovascular disease.

Authors:  Paul G Shekelle; Sally C Morton; Lara K Jungvig; Jay Udani; Myles Spar; Wenli Tu; Marika J Suttorp; Ian Coulter; Sydne J Newberry; Mary Hardy
Journal:  J Gen Intern Med       Date:  2004-04       Impact factor: 5.128

Review 5.  Recent developments in secondary prevention and cardiac rehabilitation after acute myocardial infarction.

Authors:  Hasnain Dalal; Philip H Evans; John L Campbell
Journal:  BMJ       Date:  2004-03-20

Review 6.  Artificial intelligence in personalized cardiovascular medicine and cardiovascular imaging.

Authors:  Ikram-Ul Haq; Iqraa Haq; Bo Xu
Journal:  Cardiovasc Diagn Ther       Date:  2021-06

7.  C-reactive protein response to influenza vaccination predicts cardiovascular disease risk in the Philippines.

Authors:  Thomas W McDade; Judith B Borja; Nanette Lee; Celine T Aquino; Tyler Barrett; Linda S Adair; Christopher W Kuzawa
Journal:  Biodemography Soc Biol       Date:  2020 Jan-Mar

Review 8.  Vitamin D and Calcimimetics in Cardiovascular Disease.

Authors:  Kenneth Lim; Takayuki Hamano; Ravi Thadhani
Journal:  Semin Nephrol       Date:  2018-05       Impact factor: 5.299

9.  Incremental prognostic value of coronary artery calcium score versus CT angiography among symptomatic patients without known coronary artery disease.

Authors:  Edward Hulten; Marcio Sommer Bittencourt; Brian Ghoshhajra; Daniel O'Leary; Mitalee P Christman; Michael J Blaha; Quynh Truong; Kyle Nelson; Philip Montana; Michael Steigner; Frank Rybicki; Jon Hainer; Thomas J Brady; Udo Hoffmann; Marcelo F Di Carli; Khurram Nasir; Suhny Abbara; Ron Blankstein
Journal:  Atherosclerosis       Date:  2014-01-08       Impact factor: 5.162

Review 10.  The gut microbiome as novel cardio-metabolic target: the time has come!

Authors:  Sarah Vinjé; Erik Stroes; Max Nieuwdorp; Stan L Hazen
Journal:  Eur Heart J       Date:  2013-11-11       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.